Go to
JCI Insight
Citations to this article
Russel S. Taichman, … , Rohit Mehra, Kenneth J. Pienta
Published September 4, 2007
Citation Information: J Clin Invest. 2007;117(9):2351-2361. https://doi.org/10.1172/JCI31791.
Citation Information: J Clin Invest. 2007;117(9):2351-2361. https://doi.org/10.1172/JCI31791.
Abstract
Since the effectiveness of androgen deprivation for treatment of advanced prostate cancer was first demonstrated, prevention strategies and medical therapies for prostate cancer have been based on understanding the biologic underpinnings of the disease. Prostate cancer treatment is one of the best examples of a systematic therapeutic approach to target not only the cancer cells themselves, but the microenvironment in which they are proliferating. As the population ages and prostate cancer prevalence increases, challenges remain in the diagnosis of clinically relevant prostate cancer as well as the management of the metastatic and androgen-independent metastatic disease states.
Authors
Russel S. Taichman, Robert D. Loberg, Rohit Mehra, Kenneth J. Pienta
Total citations by year
Citation information
Citations to this article (63)
| Title and authors | Publication | Year |
|---|---|---|
|
The Tight Relationship Between the Tumoral Microenvironment and Radium-223
Conte M, Tomaciello M, De Feo MS, Frantellizzi V, Marampon F, De Cristofaro F, De Vincentis G, Filippi L |
Biomedicines | 2025 |
|
Abscisic acid signaling through LANCL2 and PPARγ induces activation of p38MAPK resulting in dormancy of prostate cancer metastatic cells
Parajuli KR, Jung Y, Taichman RS |
Oncology reports | 2024 |
|
Wnt/β-catenin-driven EMT regulation in human cancers.
Xue W, Yang L, Chen C, Ashrafizadeh M, Tian Y, Sun R |
Cellular and molecular life sciences : CMLS | 2024 |
|
Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analysis for clinical translation.
Ashrafizadeh M, Zhang W, Tian Y, Sethi G, Zhang X, Qiu A |
Cancer metastasis reviews | 2024 |
|
Calcium signalling pathways in prostate cancer initiation and progression.
Silvestri R, Nicolì V, Gangadharannambiar P, Crea F, Bootman MD |
Nature Reviews Urology | 2023 |
|
Combating castration-resistant prostate cancer by co-targeting the epigenetic regulators EZH2 and HDAC.
Schade AE, Kuzmickas R, Rodriguez CL, Mattioli K, Enos M, Gardner A, Cichowski K |
PLoS Biology | 2023 |
|
Prognostic Role of Dynamic Changes in Serological Markers in Metastatic Hormone Naïve Prostate Cancer
Roy S, Sun Y, Wallis CJ, Kishan AU, Morgan SC, Spratt DE, Malone S, Saad F |
Cancers | 2023 |
|
Cytokines and Chemokines as Mediators of Prostate Cancer Metastasis
TO Adekoya, RM Richardson |
International journal of molecular sciences | 2020 |
|
Wnt Signaling Drives Prostate Cancer Bone Metastatic Tropism and Invasion
Y Wang, U Singhal, Y Qiao, T Kasputis, JS Chung, H Zhao, F Chammaa, JA Belardo, TM Roth, H Zhang, AB Zaslavsky, GS Palapattu, KJ Pienta, AM Chinnaiyan, RS Taichman, FC Cackowski, TM Morgan |
Translational oncology | 2020 |
|
Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer
AJ Armstrong, S Gupta, P Healy, G Kemeny, B Leith, MR Zalutsky, C Spritzer, C Davies, C Rothwell, K Ware, JA Somarelli, K Wood, T Ribar, P Giannakakou, J Zhang, D Gerber, M Anand, WC Foo, S Halabi, SG Gregory, DJ George, L Costa |
PloS one | 2019 |
|
Minimal residual disease in prostate cancer patients after primary treatment: theoretical considerations, evidence and possible use in clinical management
NP Murray |
Biological research | 2018 |
|
BRCA2-Associated Prostate Cancer in a Patient With Spinal and Bulbar Muscular Atrophy
V Conteduca, M Sigouros, A Sboner, CC Pritchard, H Beltran |
JCO Precision Oncology | 2018 |
|
[68Ga]PSMA-HBED-CC Uptake in Osteolytic, Osteoblastic, and Bone Marrow Metastases of Prostate Cancer Patients
JC Janssen, N Woythal, S Meißner, V Prasad, W Brenner, G Diederichs, B Hamm, MR Makowski |
Molecular Imaging and Biology | 2017 |
|
Biochemical Changes in the Niche Following Tumor Cell Invasion: B IOCHEMICAL C HANGESIN THE M ETASTATIC N ICHE
AM Decker, FC Cackowski, Y Jung, RS Taichman |
Journal of Cellular Biochemistry | 2017 |
|
The oncogenic transcription factor ERG represses the transcription of the tumour suppressor gene PTEN in prostate cancer cells
P Adamo, S Porazinski, S Rajatileka, S Jumbe, R Hagen, MK Cheung, I Wilson, M Ladomery |
Oncology Letters | 2017 |
|
Anticancer effect of triterpenes from Ganoderma�lucidum�in human prostate cancer cells
L Qu, S Li, Y Zhuo, J Chen, X Qin, G Guo |
Oncology Letters | 2017 |
|
The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease
CJ Turner, CM Edwards |
Current Osteoporosis Reports | 2016 |
|
Growth Arrest-Specific 6 (GAS6) Promotes Prostate Cancer Survival by G 1 Arrest/S Phase Delay and Inhibition of Apoptosis During Chemotherapy in Bone Marrow: GAS6 P ROMOTES PCA C ELL S URVIVAL BY G 1 A RREST
E Lee, AM Decker, FC Cackowski, LA Kana, K Yumoto, Y Jung, J Wang, L Buttitta, TM Morgan, RS Taichman |
Journal of Cellular Biochemistry | 2016 |
|
Endogenous GAS6 and Mer receptor signaling regulate prostate cancer stem cells in bone marrow
Y Jung, AM Decker, J Wang, E Lee, LA Kana, K Yumoto, FC Cackowski, J Rhee, P Carmeliet, L Buttitta, TM Morgan, RS Taichman |
Oncotarget | 2016 |
|
Habitual Tea Consumption Reduces Prostate Cancer Risk in Vietnamese Men: a Case-Control Study
Van Dong Hoang, Andy H Lee, Ngoc Minh Pham, Dan Xu, Colin W Binns |
Asian Pacific Journal of Cancer Prevention | 2016 |
|
Validation of the Kattan Nomogram for Prostate Cancer Recurrence After Radical Prostatectomy.
Ondracek RP, Kattan MW, Murekeyisoni C, Yu C, Kauffman EC, Marshall JR, Mohler JL |
Journal of the National Comprehensive Cancer Network : JNCCN | 2016 |
|
Association of fatty-acid synthase polymorphisms and expression with outcomes after radical prostatectomy
J Cheng, RP Ondracek, DC Mehedint, KA Kasza, B Xu, S Gill, G Azabdaftari, S Yao, CD Morrison, JL Mohler, JR Marshall |
Prostate Cancer and Prostatic Diseases | 2015 |
|
Integrated Multimodal Imaging of Dynamic Bone-Tumor Alterations Associated with Metastatic Prostate Cancer
JC Brisset, BA Hoff, TL Chenevert, JA Jacobson, JL Boes, S Galbán, A Rehemtulla, TD Johnson, KJ Pienta, CJ Galbán, CR Meyer, T Schakel, K Nicolay, AS Alva, M Hussain, BD Ross, N Kyprianou |
PloS one | 2015 |
|
By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer
YC Wen, WJ Lee, P Tan, SF Yang, M Hsiao, LM Lee, MH Chien |
Oncotarget | 2015 |
|
Methanolic Fractions of Ornithogalum cuspidatum Induce Apoptosis in PC-3 Prostate Cancer Cell Line and WEHI-164 Fibrosarcoma Cancer Cell Line
Hamed Asadi, Mona Orangi, Dariush Shanehbandi, Zohreh Babaloo, Abbas Delazar, Leila Mohammadnejad, Fatemeh Zare Shahneh, Samira Valiyari, Behzad Baradaran |
Advanced pharmaceutical bulletin | 2014 |
|
Why Stress is BAD for Cancer Patients
Archana Nagaraja, Guillermo N Armaiz-Pena, Susan K Lutgendorf, Anil Sood |
Journal of Clinical Investigation | 2013 |
|
Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis
AC Lassemillante, SA Doi, JD Hooper, JB Prins, OR Wright |
Endocrine | 2013 |
|
Epithelial mesenchymal transition (EMT) in prostate growth and tumor progression
Campbell M Grant, Natasha Kyprianou |
Translational andrology and urology | 2013 |
|
GAS6 receptor status is associated with dormancy and bone metastatic tumor formation
RS Taichman, LR Patel, R Bedenis, J Wang, S Weidner, T Schumann, K Yumoto, JE Berry, Y Shiozawa, KJ Pienta |
PloS one | 2013 |
|
The significance of dynamin 2 expression for prostate cancer progression, prognostication, and therapeutic targeting
B Xu, LH Teng, SD da Silva, K Bijian, SA Bashir, S Jie, M Dolph, MA Alaoui-Jamali, TA Bismar |
Cancer Medicine | 2013 |
|
REST mediates androgen receptor actions on gene repression and predicts early recurrence of prostate cancer
C Svensson, J Ceder, D Iglesias-Gato, YC Chuan, ST Pang, A Bjartell, RM Martinez, L Bott, L Helczynski, D Ulmert, Y Wang, Y Niu, C Collins, A Flores-Morales |
Nucleic Acids Research | 2013 |
|
The in vivo role of androgen receptor SUMOylation as revealed by androgen insensitivity syndrome and prostate cancer mutations targeting the proline/glycine residues of synergy control motifs
S Mukherjee, O Cruz-Rodríguez, E Bolton, JA Iñiguez-Lluhí |
The Journal of biological chemistry | 2012 |
|
Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro
R Ribeiro, C Monteiro, V Cunha, MJ Oliveira, M Freitas, A Fraga, P Príncipe, C Lobato, F Lobo, A Morais, V Silva, J Sanches-Magalhães, J Oliveira, F Pina, A Mota-Pinto, C Lopes, R Medeiros |
Journal of experimental & clinical cancer research : CR | 2012 |
|
Disseminated prostate cancer cells can instruct hematopoietic stem and progenitor cells to regulate bone phenotype
J Joseph, Y Shiozawa, Y Jung, JK Kim, E Pedersen, A Mishra, JL Zalucha, J Wang, ET Keller, KJ Pienta, RS Taichman |
Molecular cancer research : MCR | 2012 |
|
Prevalence of Prostate Cancer Metastases after Intravenous Inoculation Provides Clues into the Molecular Basis of Dormancy in the Bone Marrow Microenvironment
Jung Y, Shiozawa Y, Wang J, McGregor N, Dai J, Park SI, Berry JE, Havens AM, Joseph J, Kim JK, Patel L, Carmeliet P, Daignault S, Keller ET, McCauley LK, Pienta KJ, Taichman RS |
Neoplasia (New York, N.Y.) | 2012 |
|
Prostate Cancer Metastases Target the Hematopoietic Stem Cell Niche to Establish Footholds in Marrow
Yusuke Shiozawa, Elisabeth Pedersen, Aaron Havens, Younghun Jung, Anjali Mishra, Jeena Joseph, Jin Koo Kim, Lalit Patel, Chi Ying, Anne Ziegler, Michael Pienta, Junhui Song, Jingcheng Wang, Robert Loberg, Paul Krebsbach, Ken J. Pienta, Russell Taichman |
Journal of Clinical Investigation | 2011 |
|
A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth
W Huang, Y Fridman, RD Bonfil, CV Ustach, MK Conley-LaComb, C Wiesner, A Saliganan, ML Cher, HR Kim |
Oncogene | 2011 |
|
Steps in Prostate Cancer Progression that lead to Bone Metastasis
JK Jin, F Dayyani, GE Gallick |
International Journal of Cancer | 2011 |
|
A short account of metastatic bone disease
L Feller, B Kramer, J Lemmer |
Cancer Cell International | 2011 |
|
Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
BH Kang, M Tavecchio, HL Goel, CC Hsieh, DS Garlick, CM Raskett, JB Lian, GS Stein, LR Languino, DC Altieri |
British Journal of Cancer | 2011 |
|
Characterization of bone metastases from rapid autopsies of prostate cancer patients
R Mehra, C Kumar-Sinha, S Shankar, RJ Lonigro, X Jing, NE Philips, J Siddiqui, B Han, X Cao, DC Smith, RB Shah, AM Chinnaiyan, KJ Pienta |
Clinical cancer research | 2011 |
|
Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate Cancer
H Bonkhoff |
Prostate Cancer | 2011 |
|
Persistent, Biologically Meaningful Prostate Cancer After 1 Year of Androgen Ablation and Docetaxel Treatment
V Tzelepi, E Efstathiou, S Wen, P Troncoso, M Karlou, CA Pettaway, LL Pisters, A Hoang, CJ Logothetis, LC Pagliaro |
Journal of Clinical Oncology | 2011 |
|
Arachidonic Acid Pathway Members PLA2G7, HPGD, EPHX2, and CYP4F8 Identified as Putative Novel Therapeutic Targets in Prostate Cancer
P Vainio, S Gupta, K Ketola, T Mirtti, JP Mpindi, P Kohonen, V Fey, M Perälä, F Smit, G Verhaegh, J Schalken, KA Alanen, O Kallioniemi, K Iljin |
The American Journal of Pathology | 2011 |
|
Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [111In]-labeled CHX-A″DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell lines
J Malmberg, V Tolmachev, A Orlova |
Experimental and therapeutic medicine | 2011 |
|
Androgen regulation of epithelial-mesenchymal transition in prostate tumorigenesis
EA Matuszak, N Kyprianou |
Expert Review of Endocrinology & Metabolism | 2011 |
|
Multiple Roles of Chemokine (C-C Motif) Ligand 2 in Promoting Prostate Cancer Growth
J Zhang, Y Lu, KJ Pienta |
JNCI Journal of the National Cancer Institute | 2010 |
|
PRECLINICAL CHARACTERIZATION OF MITOCHONDRIA-TARGETED SMALL MOLECULE Hsp90 INHIBITORS, GAMITRINIBS, IN ADVANCED PROSTATE CANCER
BH Kang, MD Siegelin, J Plescia, CM Raskett, DS Garlick, T Dohi, JB Lian, GS Stein, LR Languino, DC Altieri |
Clinical cancer research | 2010 |
|
Self-rated health as a tool for estimating health-adjusted life expectancy among patients newly diagnosed with localized prostate cancer: a preliminary study
R Mohan, HA Beydoun, MA Beydoun, M Barnes-Eley, J Davis, R Lance, P Schellhammer |
Quality of Life Research | 2010 |
|
Cholesterol as a Potential Target for Castration-Resistant Prostate Cancer
AL Twiddy, CG Leon, KM Wasan |
Pharmaceutical Research | 2010 |
|
Cytoprotective Mitochondrial Chaperone TRAP-1 As a Novel Molecular Target in Localized and Metastatic Prostate Cancer
I Leav, J Plescia, HL Goel, J Li, Z Jiang, RJ Cohen, LR Languino, DC Altieri |
The American Journal of Pathology | 2010 |
|
CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis
J Zhang, L Patel, KJ Pienta |
Cytokine & Growth Factor Reviews | 2010 |
|
Targeting chemokine (C-C motif) ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic
J Zhang, L Patel, KJ Pienta |
Progress in molecular biology and translational science | 2010 |
|
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd |
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology | 2009 |
|
Prostate cancer regulatory networks
DC Altieri, LR Languino, JB Lian, JL Stein, I Leav, AJ van Wijnen, Z Jiang, GS Stein |
Journal of Cellular Biochemistry | 2009 |
|
Prostate cancer promotes CD11b positive cells to differentiate into osteoclasts
K Mizutani, S Sud, KJ Pienta |
Journal of Cellular Biochemistry | 2009 |
|
Microfluidic system for formation of PC-3 prostate cancer co-culture spheroids
AY Hsiao, Y Torisawa, YC Tung, S Sud, RS Taichman, KJ Pienta, S Takayama |
Biomaterials | 2009 |
|
Herbal extract “Songyou Yin” inhibits tumor growth and prolongs survival in nude mice bearing human hepatocellular carcinoma xenograft with high metastatic potential
XY Huang, L Wang, ZL Huang, Q Zheng, QS Li, ZY Tang |
Journal of Cancer Research and Clinical Oncology | 2009 |
|
The Chemokine CCL2 Increases Prostate Tumor Growth and Bone Metastasis through Macrophage and Osteoclast Recruitment
Mizutani K, Sud S, McGregor NA, Martinovski G, Rice BT, Craig MJ, Varsos ZS, Roca H, Pienta KJ |
Neoplasia (New York, N.Y.) | 2009 |
|
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone
Y Lu, Q Chen, E Corey, W Xie, J Fan, A Mizokami, J Zhang |
Clinical & Experimental Metastasis | 2008 |
|
The current state of preclinical prostate cancer animal models
KJ Pienta, C Abate-Shen, DB Agus, RM Attar, LW Chung, NM Greenberg, WC Hahn, JT Isaacs, NM Navone, DM Peehl, JW Simons, DB Solit, HR Soule, TA VanDyke, MJ Weber, L Wu, RL Vessella |
The Prostate | 2008 |
|
Characterization of TMPRSS2 -ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
R Mehra, SA Tomlins, J Yu, X Cao, L Wang, A Menon, MA Rubin, KJ Pienta, RB Shah, AM Chinnaiyan |
Cancer research | 2008 |
|
A Feasibility Study Evaluating the Functional Diffusion Map as a Predictive Imaging Biomarker for Detection of Treatment Response in a Patient with Metastatic Prostate Cancer to the Bone
Lee KC, Bradley DA, Hussain M, Meyer CR, Chenevert TL, Jacobson JA, Johnson TD, Galban CJ, Rehemtulla A, Pienta KJ, Ross BD |
Neoplasia (New York, N.Y.) | 2007 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)